The image files from Affymetrix miRNA 2.0 microarrays were processed in Partek Genomics Suite software version 6.6, 2012 (Partek Inc, St. Louis, MO). A list of human mature miRNAs (miRBase V15 only, n=1100) were used for the analysis. Robust microarray analysis (RMA) algorithm was used for normalization. Two way ANOVA (gender was identified as a source of variation) followed by Fisher's Least Significant Difference test was used to identify the differentially expressed miRNAs among groups. Statistical significance was defined by p<0.01 and fold-change >1.5 for comparison of healthy smokers vs healthy never-smokers; and p<0.05 and fold-change >1.5 for comparison of healthy never-smokers vs healthy smokers after 3-month smoking cessation.
Inclusion and Exclusion Criteria

Healthy nonsmokers
Inclusion criteria $ Males and females, at least 18 years old $ Provide informed consent $Normal physical examination $ Normal routine laboratory evaluation, including general hematologic studies, general serologic/immunologic studies, general biochemical analyses, and urine analysis $ HIV negative $Not pregnant (females) $ Normal PA and lateral chest X-ray $ Normal electrocardiogram (sinus bradycardia, premature atrial contractions are permissible) $ Good health without history of chronic lung disease, including asthma, and without recurrent or recent (within 3 months) acute pulmonary disease $ Not taking any medications relevant to lung disease or having an effect on the airway epithelium $ No history of allergies to medications used in the bronchoscopy procedure $ Willingness to participate in the study $ Self-reported nonsmokers, with smoking status validated by the absence of nicotine and cotinine in urine (nicotine <30 ng/ml and cotinine <50 ng/ml)
Exclusion criteria
• Unable to meet the inclusion criteria • Evidence of malignancy within the past 5 years • Current active infection or acute illness of any kind • Alcohol or drug abuse within the past 6 months
Healthy smokers
Inclusion criteria $ Males and females, at least 18 years old $ Provide informed consent $Normal physical examination $ Normal routine laboratory evaluation, including general hematologic studies, general serologic/immunologic studies, general biochemical analyses, and urine analysis $ HIV negative $Not pregnant (females) $ Normal PA and lateral chest X-ray $ Normal electrocardiogram (sinus bradycardia, premature atrial contractions are permissible) $ Good health without history of chronic lung disease, including asthma, and without recurrent or recent (within 3 months) acute pulmonary disease $ Not taking any medications relevant to lung disease or having an effect on the airway epithelium $ No history of allergies to medications used in the bronchoscopy procedure $ Willingness to participate in the study $ Self-reported current smokers with a minimum of 15 pack-yr smoking history, with current smoking status validated by urine cotinine level ≥104 ng/ml at baseline bronchoscopy [1] • The subjects underwent smoking cessation for 3 months and had no urine metabolites in their urine at the month 3 bronchoscopy assessment (nicotine <30 ng/ml and cotinine <50 ng/m)
Exclusion criteria
